Drug recall · September 23, 2020
WP Thyroid recall
Why: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
WP Thyroid, Westhroid Pure, 1.25 Grain (81.25 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-6050-2 ; b) 30 Tablets, NDC 64727-6050-4; c) 60 Tablets, NDC 64727-6050-5; d) 90 Tablets, NDC 64727-6050-6; e) 100 Tablets, NDC 64727-6050-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034
- Lots / codes
All lots with expiry between 10/2020-07/2023
- Quantity
- N/A
- Company
- RLC Labs Inc., Phoenix, AZ
- Distribution
- Nationwide in the United States
- Initiated
- August 25, 2020 · Voluntary: Firm initiated
- Classified
- September 24, 2020
- Reported
- September 23, 2020
- Ended
- November 8, 2023
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.